Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells

Metformin has emerged as a potential anticancer agent. Here, we demonstrate that metformin plays an anti-tumor role via repressing N-cadherin, independent of AMPK, in wild-type N-cadherin cancer cells. Ectopic-expression of N-cadherin develops metformin-resistant cancer cells, while suppression of N...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Rongbin, Wang, Zongwei, Wu, Shulin, Zhuo, Yangjia, Otsetov, Aleksandar G., Cai, Chao, Zhong, Weide, Wu, Chin-Lee, Olumi, Aria F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745705/
https://www.ncbi.nlm.nih.gov/pubmed/26359363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745705/
https://www.ncbi.nlm.nih.gov/pubmed/26359363

Ejemplares similares